Skip to main content

Bridgette A. Keller

Member

BAKeller@mintz.com

+1.212.692.6735

Share:

Bridgette advises clients in the health insurance industry, including managed care organizations, PBMs, and integrated delivery systems, ACOs, and providers on a variety of regulatory, fraud and abuse, and business planning matters. Her practice centers on compliance with federal health care program regulatory requirements, with a focus on reimbursement issues and value-based contracting.

Bridgette regularly counsels clients regarding risk-adjusted reimbursement programs and the practices that support them, including Medicare Advantage Organizations (MAOs) and ACOs participating in the Medicare Shared Savings Program (MSSP). Bridgette has experience conducting and defending investigations regarding fraud and abuse issues, including billing compliance related to Medicare, Medicaid, and TRICARE. She also works closely with discount medical plans (DMPOs) and other clients in the health care industry on matters relating to compliance with state regulations.

Bridgette is interested in value-based healthcare. She works closely with payors, providers, and ACOs, on a variety of innovative collaborations and has experience negotiating and papering these relationships.

With a background in health care operations, Bridgette is able to provide clients with practical insight that includes a focus on the business implications of health care regulatory and compliance, internal investigations, and fraud and abuse analyses of proposed new procedures. Bridgette applies her experience in health system administration and ethics in health care to her health law practice. Prior to practicing law, she worked as a health care ethicist at the Department of Veterans Affairs National Center for Ethics in Health Care (NCEHC) and held other health system operations positions within VHA.

Most recently, Bridgette began hosting Health Law Diagnosed, Mintz’s health law podcast and she is a frequent author on Mintz’s Health Law Viewpoints.

Experience

  • Counsels clients regarding Medicare Advantage risk adjustment compliance, including responses to OIG and CMS RADV audits.
  • Assists with communication and advocacy with federal health care program regulators, including CMS and the HHS OIG.
  • Drafts and negotiates complex services agreements between health plans and PBMs.  
  • Monitors changes and developments in state laws that impact the PBM industry and other related stakeholders.
  • Conducts internal investigations into potential fraud and abuse matters and manage multiple key stakeholders.
  • Develops and implements compliance reviews to recommend and identify compliance best practices.
  • Assisted with the defense and settlement of a five-year False Claims Act investigation conducted by multiple U.S. Attorney’s Offices and DOJ’s Civil Division on behalf of a national health care provider. We successfully convinced the Office of Inspector General for the Department of Health and Human Services not to pursue a Corporate Integrity Agreement.
  • Represented a national health care provider in a False Claims Act investigation conducted by the U.S. Attorney’s Office for the Southern District of New York. The government ultimately declined to intervene, and the relator chose to voluntarily dismiss the case.
  • Assisted with the defense of a diagnostics company in a national criminal and civil investigation involving multiple US Attorneys’ Offices and state Attorneys' General Offices. The investigation involved alleged kickback issues and billing violations.
Read less

viewpoints

ML Strategies Publishes Washington Outlook for 2016

January 20, 2016 | Blog | By Bridgette Keller

Earlier today, my colleagues at ML Strategies published the Washington Outlook for 2016, offering their insights about what we might expect from Capitol Hill and the Administration in the coming year.
Read more

The Managed Care Industry – 2015 Year in Review

January 6, 2016 | Blog | By Bridgette Keller

As we start a new year, let’s take a look back at a few hot topics that emerged in the managed care industry in 2015 and will likely be drivers of developments in 2016.
Read more
This week’s ML Strategies Health Care Update highlights the recent Department of Health and Human Services (HHS) forum on prescription drug costs, which featured players from every corner of the industry, including top government officials.
Read more
Congress returns this week, and ML Strategies has re-launched its weekly Health Care Update. This publication provides timely information on implementation of the Affordable Care Act, Congressional initiatives affecting the health care industry, and federal and state health regulatory developments.
Read more
Next week, my colleague Karen Lovitch will be co-presenting a discussion on Hot Topics in Laboratory Compliance at the American Health Lawyers Association’s Fraud and Compliance Forum in Baltimore, Maryland.
Read more

Personalized Medicine and Alternative Payment Models

August 19, 2015 | Blog | By Bridgette Keller

Earlier this month, my colleague Andy Shin at ML Strategies co-authored an article in the American Journal of Managed Care for a special issue of Evidence–Based Oncology, focusing on personalized medicine.
Read more
In a set of rules published last week, the government finalized a July 2010 interim final rule (“IFR”) related to coverage of certain preventive services and an August 2014 IFR regarding the definition of an eligible organization and the process by which an eligible organization can provide notice of its religious objection to the coverage of contraceptive services.
Read more

HRSA Takes its First Steps on 340B Rules

June 22, 2015 | Blog | By Bridgette Keller

The 340B Drug Discount Program has operated for more than 20 years with just a few governing regulations codified in 42 CFR Part 10.  Through the Affordable Care Act (“ACA”), Congress adopted several amendments to the 340B Program.
Read more

Government Announces Health Care Fraud “Takedown”

June 18, 2015 | Blog | By Brian Dunphy, Bridgette Keller

Earlier today, Attorney General Loretta Lynch announced the largest coordinated crackdown in the Medicare Fraud Strike Force’s eight-year history.  The government brought charges against 243 individuals for approximately $712 million in alleged Medicare fraud.
Read more

Over a Decade in the Making: CMS Releases Long-Awaited Medicaid Managed Care Rule

June 5, 2015 | Advisory | By Pamela Kramer, Bridgette Keller, Lauren Moldawer

On May 27, 2015, the Centers for Medicare and Medicaid Services (“CMS”) published a 653-page proposed rule affecting the thirty-nine states (plus the District of Columbia) that use managed care organizations (“MCOs”) to administer their Medicaid benefits.
Read more
Read less

News & Press

Press Release Thumbnail Mintz

Mintz announces the elevation of 12 attorneys to its partnership ranks across the US and Canada, effective January 1, 2026. These promotions build on the firm’s growth in 2025, which included 14 lateral partners spanning the firm’s geographies.

Press Release Thumbnail Mintz

173 Mintz attorneys across 53 practice areas have been recognized by Best Lawyers® in the 2026 edition of The Best Lawyers in America©. Five Mintz attorneys received 2026 “Lawyer of the Year” awards, and 61 firm attorneys were included in the 2026 edition of Best Lawyers: Ones to Watch.

Press Release Thumbnail Mintz

NEW YORK – Mintz is pleased to announce that 18 attorneys have been named New York Metro Super Lawyers and 11 attorneys have been named New York Metro Rising Stars by Super Lawyers for 2023.

Press Release Thumbnail Mintz

17 Mintz attorneys have been named New York Metro Super Lawyers and nine Mintz attorneys have been named New York Metro Rising Stars by Super Lawyers for 2022.

Press Release Thumbnail Mintz
Mintz is advising a consortium of investors led by TPG Capital and Welsh, Carson, Anderson & Stowe in their acquisition of Kindred Healthcare, Inc. The definitive agreement totals approximately $4.1 billion in cash including the assumption or repayment of net debt.
Read less

podcasts

Health Law Diagnosed – What California’s New Laws Mean for Health Care Investors

November 10, 2025 | Podcast | By Bridgette Keller, Deborah Daccord, Daniel Cody

Explore California’s new health care transaction laws in this episode of Health Law Diagnosed. Mintz experts discuss A.B. 1415, S.B. 351, and the rise of “mini HSR” rules—plus what health care entities must do now to stay compliant.

Read more

Health Law Diagnosed: The Summer / Fall 2025 PBM Policy and Legislative Update

November 4, 2025 | Podcast | By Bridgette Keller, David Gilboa

PBM policy reform heats up in Summer/Fall 2025. Tune in as Bridgette Keller and David Gilboa unpack stalled federal bills, state-level regulations, and key litigation in this episode of Health Law Diagnosed.

Read more

Health Law Diagnosed: Mintz IRA Update — Q3 2025 Edition

September 22, 2025 | Podcast | By Bridgette Keller, Hassan Shaikh

In the latest episode of Health Law Diagnosed, Of Counsel Bridgette Keller is joined by Associate Hassan Shaikh for a discussion on noteworthy developments relating to the IRA and drug pricing.

Read more

Health Law Diagnosed – Best Practices for Communicating with the FDA

July 9, 2025 | Podcast | By Bridgette Keller, Joanne Hawana, Benjamin Zegarelli

Of Counsel Bridgette Keller is joined by Joanne Hawana, Ben Zegarelli, and John Daley, as they offer advice for navigating communications with the FDA.

Read more

Health Law Diagnosed: PBM Update Spring 2025

June 10, 2025 | Podcast | By Bridgette Keller, David Gilboa

Host, Bridgette Keller is joined by Associate, David Gilboa to break down the highlights from our Spring 2025 PBM Policy and Legislative Update. In just five minutes, we cover the most impactful federal and state developments shaping the PBM landscape this season.

Read more

Health Law Diagnosed – Health Care Transaction Review Laws and the New Normal

April 24, 2025 | Podcast | By Bridgette Keller, Deborah Daccord, Daniel Cody

Host Bridgette Keller is joined by Members Deb Daccord and Dan Cody to discuses the evolving legislative and regulatory landscape impacting healthcare transactions, particularly for private equities and hedge funds.

Read more

Health Law Diagnosed – Understanding the New Massachusetts Health Care Market Review Law

March 11, 2025 | Podcast | By Bridgette Keller, Deborah Daccord, Kate Stewart, Cassandra Paolillo

Host Bridgette Keller discusses the new Massachusetts Health Care Market Review Law and what this means for health care providers, investors, and other key stakeholders. She is joined by Member Deb Daccord, Of Counsel Cassie Paolillo, and Of Counsel Kate Stewart, who share their insights on the law’s far-reaching implications.

Read more

Health Law Diagnosed – New Year's Gratitude

February 3, 2025 | Podcast | By Bridgette Keller, Alison H. Peters, Samantha Kingsbury, Theresa Carnegie, Joanne Hawana, Abdie Santiago, Stephnie John, Pamela Polevoy, Karen Lovitch, Jean D. Mancheno, Deborah Daccord, Rachel A. Alexander, Jane Haviland, David Gilboa, Kathryn Edgerton, Hassan Shaikh, Madison Castle, Laurence Freedman, Priyanka Amirneni, Samantha Hawkins, Tara E. Dwyer, Rachel Yount, Sophia Temis, Xavier Hardy

Host Of Counsel Bridgette Keller invites the Mintz Health Law team to reflect on what they’re grateful for as they prepare for the year ahead. Hear from a dynamic group of Members, Of Counsel, and Associates as they share their perspectives on what’s coming up over the horizon.

Read more

Health Law Diagnosed – The 2024 Election and Health Care Policy

January 16, 2025 | Podcast | By Bridgette Keller, Alexander Hecht

Host Of Counsel Bridgette Keller is joined by Alex Hecht, ML Strategies Executive Vice President & Director of Operations, Washington, DC, as they dive into potential health care policy changes on the horizon following the 2024 election and what stakeholders can expect in 2025.

Read more

Host Bridgette Keller, joined by Lauren Edgerton, Healthcare Director at Piper Sandler, and Kathryne Cooper, Partner at Jumpstart Nova leads a conversation around investing in women's health.

Read more
Read less

Recognition & Awards

  • Best Lawyers in America: Ones to Watch - Health Care Law (2026)

  • Included on the New York Super Lawyers Rising Star: Health Care list (2020 - 2023)

  • ABA-BNA Award for Excellence in the Study of Health Law

Read less

Involvement

  • Member, American Health Lawyers Association (AHLA)
  • Member, American Bar Association (ABA)
  • Member, American College of Healthcare Executives (ACHE)
Read less